The use of color tests for the presumptive identification of illicit substances has been an important tool used by law enforcement to establish probable cause for decades. Recently, however, color tests have received negative media attention due to their inconsistent and subjective results that can sometimes lead to wrongful arrests. Although they have been fairly effective in testing common drugs, current color tests cannot combat the constant influx of novel psychoactive substances due to their failure to clearly distinguish similarly structured compounds from one another. Common commercially available color tests can yield false positives for cocaine when testing diphenhydramine, indistinguishable results between cocaine and phencyclidine (PCP), and cannot easily detect benzylpiperazine (BZP). Photoluminescent organometallic clusters formed with copper(I) iodide (CuI) and cyclic amines have been investigated for around 40 years, but with no known application toward forensic science. The current project shows the practical implementation of copper(I) iodide to detect and identify various substances of forensic interest by photoluminescence spectral analysis of the resulting organometallic clusters. This novel method provides an innovative route for the presumptive identification of BZP, cocaine, PCP, fentanyl, opiates, piperazine-based designer drugs, and other heterocyclic alkaloids. (publisher abstract modified)
Downloads
Similar Publications
- Dual Pathways of Concealed Gun Carrying and Use from Adolescence to Adulthood over a 25-year Era of Change
- Assessing the Strength of Trace Evidence Fracture Fits through a Comprehensive, Systematic and Quantifiable Approach
- Post-burn and Post-blast Rapid Detection of Trace and Bulk Energetics by 3D-printed Cone Spray Ionization Mass Spectrometry